STOCK TITAN

Vericel (VCEL) Form 144 Filed — 10,000 Shares to Be Sold

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
144

Rhea-AI Filing Summary

Form 144 filing for Vericel Corporation (VCEL) shows a planned sale of 10,000 common shares held by the reporting person through Fidelity Brokerage Services. The filing lists an approximate aggregate market value of $357,700 for the shares to be sold and indicates the shares represent part of an option granted on 02/11/2020 and acquired on 09/02/2025, with cash payment at exercise. The issuer's total shares outstanding are shown as 50,460,205, so the proposed block is a small fraction of the company. The filing also discloses a prior sale of 10,000 common shares by the same person on 06/02/2025 for $400,924. The notice affirms the signer does not possess undisclosed material adverse information.

Positive

  • Clear compliance disclosure under Rule 144 with broker, quantity, and market value specified
  • Exercise details provided: option granted 02/11/2020 and acquired/exercised 09/02/2025 with cash payment
  • Prior sale disclosed for transparency: 10,000 shares sold 06/02/2025 for $400,924

Negative

  • None.

Insights

TL;DR: Routine insider notice of intended sale; size is immaterial relative to outstanding shares and follows a recent sale.

The Form 144 documents an intended sale of 10,000 common shares via a broker with an aggregate market value of $357,700. Given the issuer's stated 50.46 million shares outstanding, the planned sale represents roughly 0.02% of outstanding shares, which is immaterial from a market-capitalization perspective. The filing also records a prior sale of 10,000 shares on 06/02/2025 for $400,924, confirming recent liquidity activity by the same individual. This filing meets disclosure requirements under Rule 144 and provides transparency but does not, by itself, indicate a material change to the company's capital structure or operations.

TL;DR: Properly executed insider disclosure; affirms compliance with Rule 144 and includes representation about material nonpublic information.

The notice includes required seller and broker details, the acquisition method

144: Filer Information

144: Issuer Information

144: Securities Information



Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold


* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.



Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

144: Remarks and Signature

FAQ

What does Vericel Corporation's (VCEL) Form 144 report?

The Form 144 reports an intended sale of 10,000 common shares through Fidelity with an aggregate market value of $357,700.

How many shares of VCEL are outstanding according to the filing?

The filing lists 50,460,205 shares outstanding.

When were the securities acquired and how were they obtained?

The shares were reported as acquired on 09/02/2025 via exercise of an option granted on 02/11/2020, paid in cash.

Did the filer sell VCEL shares recently?

Yes. The filing discloses a sale of 10,000 common shares on 06/02/2025 for $400,924.

What attestation does the filer make in the Form 144?

The filer represents by signing that they do not know any material adverse information about the issuer that has not been publicly disclosed.
Vericel

NASDAQ:VCEL

VCEL Rankings

VCEL Latest News

VCEL Latest SEC Filings

VCEL Stock Data

1.87B
50.04M
1.06%
111.18%
10.91%
Biotechnology
Biological Products, (no Disgnostic Substances)
Link
United States
CAMBRIDGE